Stay updated on Degludec/Liraglutide vs Degludec vs Liraglutide in Chinese T2DM Clinical Trial
Sign up to get notified when there's something new on the Degludec/Liraglutide vs Degludec vs Liraglutide in Chinese T2DM Clinical Trial page.

Latest updates to the Degludec/Liraglutide vs Degludec vs Liraglutide in Chinese T2DM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the completed Chinese type 2 diabetes trial is displayed, including its eligibility criteria, study locations, design, outcome measures, results, and supporting documents.SummaryDifference92%

- Check15 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH notice says the agency is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe 403 Forbidden page’s footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous detailed study information and links. This change makes the page inaccessible and removes the core content that users expect to find on the study's ClinicalTrials.gov entry.SummaryDifference22%

Stay in the know with updates to Degludec/Liraglutide vs Degludec vs Liraglutide in Chinese T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Degludec/Liraglutide vs Degludec vs Liraglutide in Chinese T2DM Clinical Trial page.